Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating tocilizumab plus methotrexate in moderate-to-severe rheumatoid arthritis has completed; status of the study is upda…
-
CLINICAL_TRIALS research · 2010-06-11Clinical Trial Update: A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis. [Phase 1]
This clinical trial update documents a Phase 1 study assessing potential interactions among tocilizumab, methotrexate, and simvastatin in pa…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)
An observational study (NCT00705289) assessing characteristics of rheumatoid arthritis in patients treated with infliximab; results were pos…
-
FDA approval · 2010-06-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis [Phase 1]
The document reports a Phase 1 study evaluating LX3305 in combination with methotrexate for stable rheumatoid arthritis, with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2010-05-21Clinical Trial Update: Efferocytosis and Genomic Polymorphism in Autoimmune Diseases
This clinical trial update examines the relationship between efferocytosis and genomic polymorphisms in autoimmune diseases, including syste…
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing [Phase 3]
Phase 3 study comparing 80 mg adalimumab with placebo and evaluating non-inferiority of monthly 80 mg dosing versus 40 mg every other week i…
-
CLINICAL_TRIALS trial_result · 2010-05-04Clinical Trial Update: Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA [Phase 3]
Open-label Phase 3 study assessing once-weekly 50 mg etanercept in Japanese patients with rheumatoid arthritis; the trial is completed with …
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate [Phase 2]
Phase 2 safety study of SCIO-469 in patients with active rheumatoid arthritis taking methotrexate has completed.
-
FDA approval · 2010-04-26FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)
FDA approved a supplemental application for ZYBIC (meloxicam) submitted by Redmont Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) [Phase 2]
Phase 2 trial evaluating MDX-1100, an anti-CXCL10 monoclonal antibody, in combination with methotrexate for active rheumatoid arthritis has …
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: FolateScan in Autoimmune Disease [Phase 2]
A Phase 2 clinical trial of FolateScan in autoimmune diseases has completed, including rheumatoid arthritis, osteoarthritis, multiple sclero…
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: Early Migration in a High Congruent Rotating Platform Total Knee Prosthesis Design
Study results report early migration data for a high-congruence rotating platform total knee prosthesis in rheumatoid arthritis patients. Th…
-
CLINICAL_TRIALS other · 2010-03-30Clinical Trial Update: Complement Regulatory Proteins Expression and Clinical Response in Rheumatoid Arthritis (RA) Patients Treated With Rituximab
A clinical trial update examining complement regulatory protein expression and clinical response in rheumatoid arthritis patients treated wi…
-
CLINICAL_TRIALS trial_result · 2010-03-23Clinical Trial Update: Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study) [Phase 2]
Phase 2 ARISE trial results evaluate rituximab's immunomodulatory effects in the synovial tissue of patients with rheumatoid arthritis.
-
FDA approval · 2010-03-19FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for diclofenac sodium from Aurobindo Pharma Limited. This action authorizes changes to the approved …
-
FDA approval · 2010-03-17FDA Approved: INDOMETHACIN — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an original NDA for indomethacin from Fresenius Kabi USA, LLC. The approval covers indications for inflammatory and musculo…
-
CLINICAL_TRIALS trial_result · 2010-03-11Clinical Trial Update: 3DKnee™ System vs. the MJS Knee System
A clinical trial comparing the 3DKnee System to the MJS Knee System was terminated; the update lists the sponsor and the arthritis-related c…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement [NA]
Clinical trial comparing two implant surface finishes for cementless total hip replacement was terminated; results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis [Phase 2]
Phase 2 multi-dose study evaluating subcutaneous AMG 108 in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background [Phase 1]
Phase 1 multiple ascending dose study of BMS-582949 in rheumatoid arthritis patients on methotrexate has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-01Clinical Trial Update: Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate. [Phase 3]
Phase 3 trial evaluating the efficacy and safety of adalimumab in patients with active rheumatoid arthritis treated with methotrexate; resul…
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing adalimumab plus methotrexate versus methotrexate alone in subjects with early rheumatoid arthritis showed efficacy a…
-
CLINICAL_TRIALS trial_result · 2010-02-24Clinical Trial Update: Effectiveness of Occupational Therapy in Patients With Rheumatoid Arthritis(RCT) [NA]
This completed randomized trial evaluated the effectiveness of occupational therapy for patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2010-02-22Clinical Trial Update: Association of Fear of Falling and Physical Activity in Rheumatoid Arthritis Comparison Before and After Biological Therapy
This clinical trial update examines the association between fear of falling and physical activity in rheumatoid arthritis. It compares measu…